本页面由Tiger Trade Technology Pte. Ltd.提供服务

Fortress Biotech Inc.

2.31
-0.0450-1.91%
成交量:31.88万
成交额:74.14万
市值:7,422.70万
市盈率:-32.93
高:2.45
开:2.40
低:2.27
收:2.35
52周最高:4.53
52周最低:1.33
股本:3,220.26万
流通股本:2,351.11万
量比:0.71
换手率:1.36%
股息:- -
股息率:- -
每股收益(TTM):-0.0700
每股收益(LYR):-0.0700
净资产收益率:-108.74%
总资产收益率:-26.62%
市净率:1.49
市盈率(LYR):-32.93

数据加载中...

2024/07/05

重要事件披露

Form 8-K - Current report
2024/06/28

重要事件披露

Form 8-K - Current report
2024/06/28

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/06/25

SEC问询函

Form CORRESP - Correspondence
2024/06/25

重要事件披露

Form 8-K - Current report
2024/05/31

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/05/31

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/05/29

SEC问询函

Form CORRESP - Correspondence
2024/05/29

重要事件披露

Form 8-K - Current report
2024/05/17

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/05/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/05/15

重要事件披露

Form 8-K - Current report
2024/05/15

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/04/17

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/03/29

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/03/28

重要事件披露

Form 8-K - Current report
2024/03/22

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/27

重要事件披露

Form 8-K - Current report
2024/01/03

重要事件披露

Form 8-K - Current report